FindTrial
Sign In

A Study To Evaluate The Effect Of Virechana Karma With Danti Haritaki In The Management Of Eka-Kushtha (Plaque Psoriasis)

A Randomized Controlled Trial To Evaluate The Effect Of Virechana Karma With Danti Haritaki In The Management Of Eka-Kushta (Plaque Psoriasis) - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/09/073509
Enrollment
30
Registered
2024-09-06
Start date
Unknown
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L408- Other psoriasis

Interventions

None listed

Sponsors

Yogita Ahlawat
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients fulfilling the classical signs and symptoms of Eka Kushta. Patients fit for Virechana Karma will be taken for study

Exclusion criteria

Exclusion criteria: Patients suffering from Psoriatic Arthritis. Patient unfit for virechana karma.

Design outcomes

Primary

MeasureTime frame
To reduce the signs and symptoms of Eka-kushta (Plaque Psoriasis) using PSORIASIS AREA AND SEVERITY INDEXTimepoint: Total duration 13 to 25 Days—

Secondary

MeasureTime frame
Improvement in Quality of lifeTimepoint: 1 week after Samsarjana krama—

Countries

India

Contacts

Public ContactDr Yogita Ahlawat

Sri Jayendra Saraswathi Ayurveda College and Hospital

drcrdayu@gmail.com9444123506

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026